Accelerated Bio Email Format

Biotechnology ResearchPennsylvania, United States11-50 Employees

Accelerated Biosciences Corp. develops and commercializes human trophoblast stem cells derived from the trophectoderm of embryos from women with ectopic pregnancies, noting ethical sourcing and immune-privileged properties. These cells provide a versatile pluripotent platform for basic research, disease modeling, toxicology testing, drug discovery, and cell therapy development. 

Based in Philadelphia, Pennsylvania, the company serves researchers and organizations in biotechnology and pharmaceuticals that require scalable, well-characterized hTSCs for assay development and product development. Its collaborations illustrate its breadth, including a 2024 partnership with Pluristyx to develop clinical-grade induced pluripotent stem cell lines from a newly developed starting material. Accelerated Biosciences positions itself within the biotechnology research sector as a supplier and collaborator for regenerative medicine, toxicology, and related applications.

Get verified Accelerated Bio emails free

Company overview Employee directory